Uprosertib
Uprosertib (GSK2141795) is a selective, ATP-competitive, and orally bioavailable Akt inhibitor with IC50 of 180 nM, 328 nM, and 38 nM for Akt 1, 2 and 3, respectively. Phase 2.
Product Specifications
CAS Number
1047634-65-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
429.25
Molecular Formula
C18H16Cl2F2N4O2
Notes
Research use only, not for human use.
Receptor
Akt1| Akt2| Akt3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1215113-01 0.02 mg (E-Coli)
Recombinant Rickettsia peacockii NADH-quinone oxidoreductase subunit I (nuoI)
Ask
View Details 
MBS1215113-02 0.1 mg (E-Coli)
Recombinant Rickettsia peacockii NADH-quinone oxidoreductase subunit I (nuoI)
Ask
View Details 
MBS1215113-03 0.02 mg (Yeast)
Recombinant Rickettsia peacockii NADH-quinone oxidoreductase subunit I (nuoI)
Ask
View Details MBS1215113-04 0.1 mg (Yeast)
Recombinant Rickettsia peacockii NADH-quinone oxidoreductase subunit I (nuoI)
Ask
View Details MBS1215113-05 0.02 mg (Baculovirus)
Recombinant Rickettsia peacockii NADH-quinone oxidoreductase subunit I (nuoI)
Ask
View Details MBS1215113-06 0.02 mg (Mammalian-Cell)
Recombinant Rickettsia peacockii NADH-quinone oxidoreductase subunit I (nuoI)
Ask
View Details